Research Engineer, PhD at CNRS

LIMMS/CNRS-IIS, The University of Tokyo, Lille, France
SMMiL-E project



  • 2015 – Ph.D in Molecular and Cellular Biology, Biochemistry option Parasitology. University of Lille
  • 2012 – Master Degree in Biology and Health, University of Lille


  • Dec 2020-Present : Research Engineer
    Vascularized organ-on-chip approaches 
    SMMiL-E team, Supervision Dr. Fabrice Soncin
  • Sept 2019-Nov2020 : Research Engineer
    Cancer and Immunotherapy : CAR T cells 
    Team Factor of persistence of leukemic cells, CANTHER. Supervision Dr. Suman Mitra 
  • Dec 2018-Sept 2019 : Research Engineer
    Endogenous mechanisms of tumor endothelial inactivation
    SMMiL-E team. Supervision Dr. Fabrice Soncin
  • Oct 2015-Mar 2016 : Post-doctoral research fellow : 
    Caraterization of Plasmodium falciparum proteins 
    Equipe 2, Center of Infection and Immunitiy of Lille. Supervision Dr. Jamal Khalife
  • 2012-2015 : Ph.D student
    Molecular and functional studies of 2 regulators of PP1 : I2 and EIF2β in Plasmodium falciparum
    Equipe 2, Center of Infection and Immunitiy of Lille. Supervision Dr. Jamal Khalife


  • Characterization of a Protein Phosphatase type-1 and a kinase anchoring protein in Plasmodium falciparum.
    Frontiers in microbiology. Lenne A, De Witte C, Tellier G, Hollin T, Aliouat el M, Martoriati A, Cailliau K, Saliou JM, Khalife J, Pierrot C., 2018.
  • Identification of Plasmodium falciparum translation initiation eIF2β subunit : direct interaction with and control of Protein Phosphatase type 1.
    Frontiers in Microbiology. Tellier G, Lenne A, Cailliau-Maggio K, Cabezas-Cruz A, Valdés J, Martoriati A, Aliouat el M, Gosset P, Delaire B, Fréville A, Pierrot C and Khalife J., 2016.
  • Identification of a Plasmodium falciparum Inhibitor-2 motif involved in the binding and regulation activity of protein phosphatase type 1.
    FEBS J. Tellier G, Fréville A, Vandomme A, Pierrot C, Vicogne J, Cantrelle FX, Martoriati A, Cailliau-Maggio K, Khalife J, Landrieu I., 2014.
  • Plasmodium falciparum encodes a conserved active inhibitor-2 for Protein Phosphatase type 1 : perspectives for novel anti-plasmodial therapy.
    BMC Biol. Fréville A, Cailliau-Maggio K, Pierrot C, Tellier G, Kalamou H, Lafitte S, Martoriati A, Pierce RJ, Bodart JF, Khalife J., 2013.